Dabur India Merger & Restructuring
Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.
Dabur received a SEBI administrative warning for delayed disclosure of a USFDA warning letter. No monetary penalty or financial impact is reported.
Consolidated revenue grew 11.6%, the second straight double-digit quarter. India standalone grew 8.9%, and India FMCG grew 10.7% on 5.5% volume and 5.2% price. Management reiterated double-digit full-year guidance and called its M&A progress red.
Dabur India Ltd has allotted 480 equity shares of Re. 1 each under its Employees Stock Option Scheme 2000. This increases the total paid-up equity capital to Rs. 177.40 Crore.